Investor & Media Information


On this page, you will find information about the newest news and press releases. If you want to get more information about the company history, you can find out more here.

ImmUnion presentation at the Rooftop Pitch Potsdam

We were proud to present our revolutionary technology platform ImmUnion at the second Rooftop Pitch Potsdam.
The Rooftop Pitch Potsdam offers startup companies from different disciplines the opportunity to meet investors, business angels and other project interested parties above the rooftops of Potsdam. ImmUnion was one of the selected projects that got the unique chance to be presented.

August 31, 2021|

ImmUnion develops SARS-CoV-2_ImmunoJunction

ImmUnion started with the development of SARS-CoV-2 ImmunoJunction for the passive vaccination via the intranasal route. The goal is to develop a product for the use in the early stage of the disease and which the patient can administrate on his own. This would avoid the traveling of infectious humans to visit a doctor or a hospital. In connection with a telediagnosis SARS-CoV-2_ImmunoJunction can be shipped to the patients home for self-treatment.

May 8, 2021|